According to an analysis from RNCOS in “Global Sleep Apnea Market Outlook 2020” report, the global sleep apnea therapeutic devices market is anticipated to grow at a CAGR of 7.5% during the forecast period (2015-2020). The market growth is expected mainly due to the growing incidences of sleep-related breathing disorders and increasing awareness about sleep apnea coupled with the rising incidences of obesity.
According to the analysis, conventional PAP devices continue to dominate the market in terms of the therapeutic devices used for the treatment of sleep apnea; however it is the oral appliances segment that is expected to witness the maximum growth in the coming years. This high growth is likely to be driven by the fact that oral appliances are small and discreet and easily potable as compared to the conventional devices.
Also, in terms of application of the devices, obstructive sleep apnea is most commonly observed amongst all the three types of sleep apnea (obstructive, central, and mixed); however, central sleep apnea has an increasing incidence in patients with heart diseases. In terms of geography, North America is the largest market for sleep apnea therapeutic devices market, but it is the Asia Pacific market that is expected to witness the highest growth, largely due to improving medical facilities, growing awareness, and increasing focus of various players in this region. The report provides information on the current scenario, market outlook on the basis of the products available, application and geography, and the future forecasts on all prominent segments of the industry till 2020.